Literature DB >> 15857221

Comparison of different fibers for in vitro production of short chain fatty acids by intestinal microflora.

Anne M Pylkas1, Lekh Raj Juneja, Joanne L Slavin.   

Abstract

The fermentation of dietary fiber in the large intestine and the by-products of this fermentation are thought to protect against colonic diseases. As it is difficult to measure the fermentation of dietary fiber in an intact animal, in vitro techniques have been developed to compare the fermentability of various dietary fibers. The objective of this project was to compare short chain fatty acid (SCFA) production with different fibers in an in vitro fermentation model. A wide range of commercially available dietary fiber sources was compared for SCFA production. Fibers were fermented with a fecal innoculum for 0, 2, 4, 8, 12, and 24 hours. SCFAs were measured by gas chromatography. SCFA production varied among the fiber sources. Hydrolyzed guar gum and galactomannan produced the greatest amounts of total SCFAs. Butyrate production was higher with the fiber sources than the glucose control. Acetate production was less for psyllium than the other fibers. Thus, different dietary fiber sources are more readily fermented by fecal microflora. These differences most likely affect the physiological differences seen among dietary fiber sources.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15857221     DOI: 10.1089/jmf.2005.8.113

Source DB:  PubMed          Journal:  J Med Food        ISSN: 1096-620X            Impact factor:   2.786


  28 in total

Review 1.  The health benefits of dietary fiber: beyond the usual suspects of type 2 diabetes mellitus, cardiovascular disease and colon cancer.

Authors:  Melissa M Kaczmarczyk; Michael J Miller; Gregory G Freund
Journal:  Metabolism       Date:  2012-03-07       Impact factor: 8.694

2.  Satiety and energy intake after single and repeated exposure to gel-forming dietary fiber: post-ingestive effects.

Authors:  A J Wanders; M Mars; K J Borgonjen-van den Berg; C de Graaf; E J M Feskens
Journal:  Int J Obes (Lond)       Date:  2013-09-13       Impact factor: 5.095

Review 3.  Dietary fibre in gastrointestinal health and disease.

Authors:  Samantha K Gill; Megan Rossi; Balazs Bajka; Kevin Whelan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-11-18       Impact factor: 46.802

Review 4.  Gut microbiota and chronic kidney disease: implications for novel mechanistic insights and therapeutic strategies.

Authors:  Wei Pan; Yongbo Kang
Journal:  Int Urol Nephrol       Date:  2017-08-28       Impact factor: 2.370

Review 5.  COPD and the gut-lung axis: the therapeutic potential of fibre.

Authors:  Annalicia Vaughan; Zoe A Frazer; Philip M Hansbro; Ian A Yang
Journal:  J Thorac Dis       Date:  2019-10       Impact factor: 2.895

Review 6.  The gut microbiome, kidney disease, and targeted interventions.

Authors:  Ali Ramezani; Dominic S Raj
Journal:  J Am Soc Nephrol       Date:  2013-11-14       Impact factor: 10.121

7.  Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults.

Authors:  Jill A Parnell; Raylene A Reimer
Journal:  Am J Clin Nutr       Date:  2009-04-22       Impact factor: 7.045

Review 8.  Gut microbiome in chronic kidney disease: challenges and opportunities.

Authors:  Anitha Nallu; Shailendra Sharma; Ali Ramezani; Jagadeesan Muralidharan; Dominic Raj
Journal:  Transl Res       Date:  2016-04-30       Impact factor: 7.012

Review 9.  Short-chain fatty acids in control of body weight and insulin sensitivity.

Authors:  Emanuel E Canfora; Johan W Jocken; Ellen E Blaak
Journal:  Nat Rev Endocrinol       Date:  2015-08-11       Impact factor: 43.330

Review 10.  Gut microbial metabolites in obesity, NAFLD and T2DM.

Authors:  Emanuel E Canfora; Ruth C R Meex; Koen Venema; Ellen E Blaak
Journal:  Nat Rev Endocrinol       Date:  2019-05       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.